Study Finds No Increased Cancer Risk With Spironolactone

Source link :

TOPLINE: Women with daily exposure to spironolactone for dermatologic conditions showed no higher risk of developing breast or gynecologic cancer than unexposed women. METHODOLOGY: Spironolactone, used off-label for several skin conditions in women, carries a warning about an increased tumor risk associated with high doses in rat models, and its antiandrogen properties have prompted hypotheses […]

Author : News Health

Publish date : 2024-03-01 04:18:32

Copyright for syndicated content belongs to the linked Source.